Refine your search

    Advanced filters

    Refine your search further by applying these filters.
    Location
      Status
      Sex
      Age

      Advanced filters

      28 trials found for solid tumor

      Recruiting
      Not yet recruiting
      2 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      2 trials recruiting
      Be6A Clinical Trials

      Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.

      Recruiting
      NCT05355701
      A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

      Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

      Male or Female
      16+ years
      38study location(s)
      Recruiting
      NCT06758401
      This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

      Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

      Male or Female
      18+ years
      22study location(s)
      Recruiting
      NCT03460977
      Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

      Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

      Male or Female
      18+ years
      85study location(s)
      Recruiting
      NCT06799533
      A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

      Malignant Melanoma, Melanoma, Metastatic Melanoma, Solid Tumors

      Male or Female
      18+ years
      9study location(s)
      Recruiting
      NCT06974734
      A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

      Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal, Malignant Melanoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

      Male or Female
      18+ years
      7study location(s)
      Recruiting
      NCT04389632
      A Study of Sigvotatug Vedotin in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      131study location(s)
      Recruiting
      NCT06704724
      A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

      Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

      Male or Female
      18+ years
      14study location(s)
      Recruiting
      NCT05208762
      A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

      Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

      Male or Female
      18+ years
      45study location(s)
      Recruiting
      NCT04879329
      A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      188study location(s)
      Recruiting
      NCT05911295
      Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

      Urothelial Carcinoma

      Male or Female
      18+ years
      302study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      Recruiting
      Not yet recruiting

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.